.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Farmers Insurance
Medtronic
Cipla
Argus Health
Boehringer Ingelheim
Chinese Patent Office
Deloitte
QuintilesIMS
Express Scripts

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020482

« Back to Dashboard
NDA 020482 describes PRECOSE, which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from four suppliers. Additional details are available on the PRECOSE profile page.

The generic ingredient in PRECOSE is acarbose. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the acarbose profile page.

Summary for 020482

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details

Pharmacology for NDA: 020482

Mechanism of Actionalpha Glucosidase Inhibitors

Medical Subject Heading (MeSH) Categories for 020482

Suppliers and Packaging for NDA: 020482

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRECOSE
acarbose
TABLET;ORAL 020482 NDA Aphena Pharma Solutions - Tennessee, LLC 43353-908 43353-908-09 9000 TABLET in 1 BOTTLE, PLASTIC (43353-908-09)
PRECOSE
acarbose
TABLET;ORAL 020482 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-951 43353-951-09 9000 TABLET in 1 BOTTLE (43353-951-09)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Sep 6, 1995TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Sep 6, 1995TE:ABRLD:Yes

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:May 29, 1997TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020482

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare
PRECOSE
acarbose
TABLET;ORAL020482-001Sep 6, 1995► Subscribe► Subscribe
Bayer Hlthcare
PRECOSE
acarbose
TABLET;ORAL020482-004May 29, 1997► Subscribe► Subscribe
Bayer Hlthcare
PRECOSE
acarbose
TABLET;ORAL020482-002Sep 6, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Fuji
Fish and Richardson
McKinsey
Cerilliant
Moodys
AstraZeneca
Accenture
Healthtrust
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot